Guardant Health Snags $30M For Tumor Sequencing
Redwood City-based Guardant Health has raised $30M in a Series B funding, to go towards development of a no-invasive, tumor sequencing test. The funding was led by Khosla Ventures, and also included Sequoia Capital and Perjman Mar Ventures. Guardant Health is led by Helmy Eltoukhy, and is aimed at diagnosing cancer.
posted on Wednesday, April 23, 2014 (Link to more information)
Related companies:
Guardant Health, Inc.
Related stories:
> Guardant Health Gets $360M
> Guardant Health Gains $100M
> Guardant Health Finds $50M
> uBiome Raises $22M Funding, Launches Gut Biome Testing Service
> Overclock Labs Snags $1.3M For Cloud Management
silicontap.com Home